A method of determining the precise molecular structure of the inhibitors by analyzing the diffraction patterns of X-rays off the crystal lattice of the compound.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
(1-{[2-(tert-Butyl-dimethyl-silanyloxy)-3,3,3-trifluoro-1-isopropyl-propylcarbamoyl]-methyl}-2-oxo-6-phenyl-1,2-dihydro-pyridin-3-yl)-carbamic acid methyl ester
4,4-Dimethyl-1-phenyl-2-(1-phenyl-3,3-bis-trifluoromethyl-1,3-dihydro-benzo[c][1,2]oxasilol-1-yl)-pentan-1-ol
